» Articles » PMID: 8370703

Modulatory Effect of the Renin-angiotensin System on the Plasma Levels of Calcitonin Gene-related Peptide in Normal Man

Overview
Specialty Endocrinology
Date 1993 Sep 1
PMID 8370703
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Calcitonin gene-related peptide (CGRP) has positive chronotropic and inotropic effects in animals and humans, and produces the most potent vasodilation known for an endogenous peptide. Yet, a physiological role for CGRP in the regulation of vascular tone and blood pressure has not been demonstrated. We studied the effects of 1) assumption of the upright position and 2) iv infusion of angiotensin-II (sequential doses of 8, 16, and 32 ng/kg.min, each dose for 20 min) in eight normal subjects (four men). Serial venous blood samples were taken to determine the plasma CGRP, epinephrine, norepinephrine, and aldosterone levels and PRA. Blood pressure and heart rate were continuously monitored at the finger with a Finapres 2300 instrument. After assumption of the upright posture, a quick rise in plasma CGRP levels was observed together with the expected increases in plasma norepinephrine and aldosterone and PRA. A transient increment was also observed for diastolic blood pressure and heart rate. Angiotensin-II infusion caused dose-dependent increases in plasma CGRP and aldosterone concentrations, already significant at the lowest infusion rate and parallel with the blood pressure rise. Plasma catecholamines significantly increased only at higher infusion rates. Our data demonstrate that modifications of plasma CGRP concentrations are part of the normal response to postural and vasomotor changes. These findings suggest a physiological role for CGRP in regulation of the peripheral vascular tone and possibly blood pressure in man.

Citing Articles

Effect of CGRP inhibitors on interictal cerebral hemodynamics in individuals with migraine.

Carter S, Cucchiara B, Reehal N, Hamilton K, Kaiser E, Favilla C Front Neurol. 2024; 15:1399792.

PMID: 38746660 PMC: 11091725. DOI: 10.3389/fneur.2024.1399792.


Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles-A Narrative Review.

Bonura A, Brunelli N, Marcosano M, Iaccarino G, Fofi L, Vernieri F Int J Mol Sci. 2023; 24(18).

PMID: 37762283 PMC: 10530509. DOI: 10.3390/ijms241813979.


Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis.

Mutiawati E, Syahrul S, Fahriani M, Fajar J, Mamada S, Maliga H F1000Res. 2021; 9:1316.

PMID: 33953911 PMC: 8063523. DOI: 10.12688/f1000research.27334.2.


COVID-19 is a Real Headache!.

Bolay H, Gul A, Baykan B Headache. 2020; 60(7):1415-1421.

PMID: 32412101 PMC: 7272895. DOI: 10.1111/head.13856.


Increased receptor activity-modifying protein 1 in the nervous system is sufficient to protect against autonomic dysregulation and hypertension.

Sabharwal R, Mason B, Kuburas A, Abboud F, Russo A, Chapleau M J Cereb Blood Flow Metab. 2018; 39(4):690-703.

PMID: 29297736 PMC: 6446426. DOI: 10.1177/0271678X17751352.